CCIA
LUNG icon

Campbell & Co Investment Adviser’s Pulmonx LUNG Stock Holding History

Campbell & Co Investment Adviser’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,244
Closed -$130K – 1319
2025
Q1 		$130K Buy
19,244
+6,186
+47% +$43.8K 0.01% 971
2024
Q4 		$88.7K Buy
+13,058
New +$86K 0.01% 1011
2024
Q2 		– Sell
-12,609
Closed -$117K – 1221
2024
Q1 		$117K Sell
12,609
-73,063
-85% -$857K 0.01% 1057
2023
Q4 		$1.09M Buy
85,672
+40,292
+89% +$420K 0.1% 349
2023
Q3 		$469K Buy
45,380
+26,019
+134% +$301K 0.06% 544
2023
Q2 		$254K Buy
+19,361
New +$237K 0.05% 725

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Campbell & Co Investment Adviser's LUNG Position: Q2 2025 in Review

Campbell & Co Investment Adviser sold out of Pulmonx (LUNG) in Q2 2025, closing a stake of 19,244 shares — an estimated $130K sold.

Campbell & Co Investment Adviser first reported a position in LUNG in Q2 2023 and held it in 6 quarters. The position peaked at $1.09M in Q4 2023. 113 funds tracked by Wall St. Rank hold LUNG as of Q2 2025.

  • Campbell & Co Investment Adviser reported no remaining Pulmonx position as of Q2 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 19,244 Pulmonx shares in Q2 2025, an estimated $130K.
  • Campbell & Co Investment Adviser first reported a position in Pulmonx in Q2 2023 and held it in 6 quarters.
  • Campbell & Co Investment Adviser's Pulmonx position peaked at $1.09M in Q4 2023.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q2 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2025, filed 7 Aug 2025.